Vladimir Sorin

634 total citations
9 papers, 551 citations indexed

About

Vladimir Sorin is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Vladimir Sorin has authored 9 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Vladimir Sorin's work include RNA modifications and cancer (2 papers), Cancer Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Vladimir Sorin is often cited by papers focused on RNA modifications and cancer (2 papers), Cancer Research and Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Vladimir Sorin collaborates with scholars based in Israel, United States and France. Vladimir Sorin's co-authors include Imad Matouk, Michal Gilon, Eli Raveh, Tatiana Birman, Abraham Czerniak, Rasha Abu-lail, Abraham Hochberg, Avraham Hochberg, David Halle and Yakov Fellig and has published in prestigious journals such as American Journal of Kidney Diseases, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research and Oncotarget.

In The Last Decade

Vladimir Sorin

9 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vladimir Sorin Israel 8 435 431 81 56 47 9 551
Pan Sun China 9 256 0.6× 291 0.7× 46 0.6× 113 2.0× 27 0.6× 15 486
Ping Zhan China 10 213 0.5× 271 0.6× 78 1.0× 97 1.7× 29 0.6× 27 463
R. Buurman Germany 8 248 0.6× 339 0.8× 39 0.5× 65 1.2× 79 1.7× 23 482
Qiyao Zhang China 12 289 0.7× 395 0.9× 24 0.3× 61 1.1× 22 0.5× 28 486
Bong-Kyeong Oh South Korea 10 81 0.2× 229 0.5× 98 1.2× 71 1.3× 38 0.8× 15 393
Ting Lei China 10 196 0.5× 245 0.6× 26 0.3× 87 1.6× 13 0.3× 16 333
Robyn M. Jong United States 5 403 0.9× 435 1.0× 33 0.4× 35 0.6× 20 0.4× 7 512
Masafumi MURAI Japan 7 106 0.2× 318 0.7× 106 1.3× 71 1.3× 40 0.9× 19 430
Yangjun Wu China 11 384 0.9× 430 1.0× 44 0.5× 46 0.8× 25 0.5× 22 537
Ceen‐Ming Tang United Kingdom 6 151 0.3× 160 0.4× 150 1.9× 91 1.6× 74 1.6× 8 419

Countries citing papers authored by Vladimir Sorin

Since Specialization
Citations

This map shows the geographic impact of Vladimir Sorin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vladimir Sorin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vladimir Sorin more than expected).

Fields of papers citing papers by Vladimir Sorin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vladimir Sorin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vladimir Sorin. The network helps show where Vladimir Sorin may publish in the future.

Co-authorship network of co-authors of Vladimir Sorin

This figure shows the co-authorship network connecting the top 25 collaborators of Vladimir Sorin. A scholar is included among the top collaborators of Vladimir Sorin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vladimir Sorin. Vladimir Sorin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Matouk, Imad, David Halle, Eli Raveh, et al.. (2015). The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget. 7(4). 3748–3765. 107 indexed citations
2.
Matouk, Imad, Eli Raveh, Rasha Abu-lail, et al.. (2014). Oncofetal H19 RNA promotes tumor metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(7). 1414–1426. 203 indexed citations
3.
Sorin, Vladimir, Patricia Ohana, Tatiana Birman, et al.. (2012). H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer. ISRN Oncology. 2012. 1–7. 28 indexed citations
4.
Sorin, Vladimir. (2011). Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liver. International Journal of Oncology. 39(6). 1407–12. 20 indexed citations
5.
Sorin, Vladimir, Yakov Fellig, Tatiana Birman, et al.. (2010). Use of H19 Gene Regulatory Sequences in DNA-Based Therapy for Pancreatic Cancer. Journal of Oncology. 2010. 1–10. 52 indexed citations
6.
Aeed, Hussein, Vladimir Sorin, Mark Shahmurov, et al.. (2009). Evaluation of the 13C-Octanoate Breath Test as a Surrogate Marker of Liver Damage in Animal Models. Digestive Diseases and Sciences. 55(6). 1589–1598. 13 indexed citations
7.
Czerniak, Abraham, Tally Levy, Imad Matouk, et al.. (2009). Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. Journal of Translational Medicine. 7(1). 69–69. 116 indexed citations
8.
Shirin, Haim, Hussein Aeed, Vladimir Sorin, et al.. (2008). Utility of a 13C‐methacetin breath test in evaluating hepatic injury in rats. Journal of Gastroenterology and Hepatology. 23(11). 1762–1768. 11 indexed citations
9.
Sorin, Vladimir, et al.. (2002). Fecal incontinence secondary to CAPD. American Journal of Kidney Diseases. 41(1). e2.1–e2.2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026